Patents by Inventor Mika Olli Kristian Sarkela

Mika Olli Kristian Sarkela has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240090851
    Abstract: Various methods and systems are provided for monitoring and displaying a patient status. In one example, the patient monitoring system includes a display device configured to display a patient status view include on or more multidimensional plots overlaying more than one of real time values, historical values, and upper and lower threshold values for a plurality of patient parameters, and additionally being configured to display an abbreviated representation of the one or more multidimensional plots that can be reached directly from the patient status view. The abbreviated representation is displayed in an unlaunched state, and displays a limited version of the respective multidimensional plot and is selectable to launch and enable the respective multidimensional plot to be seen.
    Type: Application
    Filed: September 15, 2022
    Publication date: March 21, 2024
    Inventors: Mika Olli Kristian Särkelä, Helena Liisa Anneli Aito, Matti Juhani Laitinen, Milvi Kristiina Soosalu, Virpi Kristiina Lahdenmäki
  • Patent number: 11793937
    Abstract: A method of monitoring depth of muscle relaxation of a patient includes determining a sedative drug effect of one or more sedative drugs on a patient based on at least one of drug delivery information and measured nervous system information. The sedative drug effect is then compared to a sedation criterion and, if the sedative drug effect fulfills the sedation criterion, then a neuromuscular transmission (NMT) monitor is controlled to apply a series of stimulation to a nerve of a patient and muscle responses of the patient are measured to obtain an NMT baseline. A neuromuscular blocking agent (NMBA) notice is then generated on a user interface after obtaining the NMT baseline.
    Type: Grant
    Filed: March 25, 2020
    Date of Patent: October 24, 2023
    Assignee: GE Precision Healthcare LLC
    Inventor: Mika Olli Kristian Särkelä
  • Publication number: 20210299351
    Abstract: A method of monitoring depth of muscle relaxation of a patient includes determining a sedative drug effect of one or more sedative drugs on a patient based on at least one of drug delivery information and measured nervous system information. The sedative drug effect is then compared to a sedation criterion and, if the sedative drug effect fulfills the sedation criterion, then a neuromuscular transmission (NMT) monitor is controlled to apply a series of stimulation to a nerve of a patient and muscle responses of the patient are measured to obtain an NMT baseline. A neuromuscular blocking agent (NMBA) notice is then generated on a user interface after obtaining the NMT baseline.
    Type: Application
    Filed: March 25, 2020
    Publication date: September 30, 2021
    Applicant: GE Precision Healthcare LLC
    Inventor: Mika Olli Kristian Särkelä
  • Publication number: 20210076982
    Abstract: A method of monitoring depth of muscle relaxation of a patient includes applying a series of stimulations to a nerve of a patient and measuring muscle responses thereto. A maximal stimulus current, a supramaximal stimulus current, and/or a submaximal stimulus current are determined based on the muscle responses, wherein the maximal stimulus current is a current at which a maximal muscle response is produced from stimulating the nerve, the supramaximal stimulus current is greater than or equal to the maximal stimulus current, and the submaximal stimulus current is less than the maximal stimulus current. A first set of stimulations are applied to the nerve of the patient. Either the supramaximal stimulus current or the submaximal stimulus current are then selected for a subsequent series of stimulations based on the measured muscle responses to the first series of stimulations, and the subsequent series of stimulations are performed accordingly to monitor the patient's depth of muscle relation.
    Type: Application
    Filed: September 12, 2019
    Publication date: March 18, 2021
    Applicant: GE Precision Healthcare LLC
    Inventors: Mika Olli Kristian Sarkela, Mari Johanna Partio
  • Patent number: 10780239
    Abstract: A system for controlling patient sedation and spontaneous breathing intensity includes a ventilator system that delivers ventilation to the patient. The system further includes a spontaneous breathing control module configured to determine a first spontaneous breathing intensity at a first sedative status of the patient, and a second spontaneous breathing intensity at a second sedative status of the patient. A sedation/breathing relationship is then defined between spontaneous breathing intensity and sedative status for the patient based on the first and second sedative statuses and the first and second spontaneous breathing intensities. The spontaneous breathing control module then receives a desired spontaneous breathing intensity for the patient and determines a desired sedative status that achieves that desired spontaneous breathing intensity based on the sedation/breathing relationship.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: September 22, 2020
    Assignee: General Electric Company
    Inventors: Mika Olli Kristian Sarkela, Erkki Heinonen
  • Publication number: 20190358418
    Abstract: A system for controlling patient sedation and spontaneous breathing intensity includes a ventilator system that delivers ventilation to the patient. The system further includes a spontaneous breathing control module configured to determine a first spontaneous breathing intensity at a first sedative status of the patient, and a second spontaneous breathing intensity at a second sedative status of the patient. A sedation/breathing relationship is then defined between spontaneous breathing intensity and sedative status for the patient based on the first and second sedative statuses and the first and second spontaneous breathing intensities. The spontaneous breathing control module then receives a desired spontaneous breathing intensity for the patient and determines a desired sedative status that achieves that desired spontaneous breathing intensity based on the sedation/breathing relationship.
    Type: Application
    Filed: May 24, 2018
    Publication date: November 28, 2019
    Applicant: General Electric Company
    Inventors: Mika Olli Kristian Sarkela, Erkki Heinonen
  • Publication number: 20110015537
    Abstract: A method, apparatus and computer program product are disclosed for monitoring specific cerebral activity of a subject. Occurrences of a predetermined event are detected in each of at least two brain wave signals acquired from a subject, wherein the predetermined event is indicative of a specific cerebral activity. Based on the detecting, an event information signal is produced for each of the at least two brain wave signals, thereby to obtain at least two event information signals, each event information signal being indicative of occurrences of the predetermined event in respective brain wave signal.
    Type: Application
    Filed: July 15, 2009
    Publication date: January 20, 2011
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Ville Henri Virkkala, Mika Olli Kristian Sarkela